Danielle Alvarez
Areas of Focus
Overview
Danielle Alvarez is an associate in the Litigation and Health Care groups in Crowell & Moring’s Denver office. Danielle represents clients in a variety of litigation matters. Her practice includes complex class action litigation and health care litigation work pursuing recovery of money lost as a result of fraud.
Career & Education
- University of Florida, B.A., international studies, 2019
- University of Florida, B.A., political science, 2019
- The George Washington University Law School, J.D., 2022
- Colorado
Danielle's Insights
Client Alert | 2 min read | 12.11.23
Federal Trade Commission: The AI Watchdog
The rapid and evolving development of artificial intelligence (“AI”) has alarmed various government agencies, especially the Federal Trade Commission (“FTC”). On November 21, the FTC approved an omnibus resolution simplifying the process for its staff to issue civil investigative demands (“CIDs”) in AI investigations. This resolution comes on the heels of President Biden’s October executive order establishing new standards for AI safety and security. Both actions may increase exposure for businesses involved in the use of products and services that use or are produced through AI. Businesses should be knowledgeable about their use and marketing of AI and ensure their products and conduct do not pose a risk to consumers or competition.
Client Alert | 2 min read | 04.27.23
Health Product Advertisers Beware: Tidal Wave of FTC Notices Could Spawn Litigation and Hefty Fines
Client Alert | 3 min read | 03.06.23
Insights
Practices
Danielle's Insights
Client Alert | 2 min read | 12.11.23
Federal Trade Commission: The AI Watchdog
The rapid and evolving development of artificial intelligence (“AI”) has alarmed various government agencies, especially the Federal Trade Commission (“FTC”). On November 21, the FTC approved an omnibus resolution simplifying the process for its staff to issue civil investigative demands (“CIDs”) in AI investigations. This resolution comes on the heels of President Biden’s October executive order establishing new standards for AI safety and security. Both actions may increase exposure for businesses involved in the use of products and services that use or are produced through AI. Businesses should be knowledgeable about their use and marketing of AI and ensure their products and conduct do not pose a risk to consumers or competition.
Client Alert | 2 min read | 04.27.23
Health Product Advertisers Beware: Tidal Wave of FTC Notices Could Spawn Litigation and Hefty Fines
Client Alert | 3 min read | 03.06.23
